GeneDx

Yahoo Finance • 9 days ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GAITHERSBURG, Md., September 18, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Thomas Fuchs, Dr.sc., Chief AI Officer at Eli Lilly... Full story

Mentioned:

Yahoo Finance • 2 months ago

GeneDx raises 2025 revenue guidance to $415M and exome/genome revenue growth to 52% while accelerating NICU and pediatric market expansion

Earnings Call Insights: GeneDx Holdings Corp. (WGS) Q2 2025 MANAGEMENT VIEW * Katherine A. Stueland, President and CEO, highlighted that GeneDx achieved a milestone by delivering over $100 million in quarterly revenue for the first tim... Full story

Mentioned:

Yahoo Finance • 4 months ago

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

Company deploying AI to scale industry-leading rare disease dataset to diagnose growing number of patients with genetic disease, published in the American Journal of Medical Genetics GAITHERSBURG, Md., May 22, 2025--(BUSINESS WIRE)--GeneD... Full story